Prioritizing precision medicine in pulmonary hypertension

The Center for Pulmonary Vascular Biology and Medicine at the University of Pittsburgh and UPMC is a multi-disciplinary clinical and research center for pulmonary vascular disease with a focus on comprehensive and state-of-the-art care of our patients.

In the past, pulmonary hypertension (PH) was considered a rare disease affecting only a few unfortunate people. Today, we know countless individuals suffer from this disease with tragic consequences. But because PH has been an historically neglected disease, advances have been slowed by the lack of sophisticated technology, little financial support, and a small number of physicians and scientists dedicated to its study.

The Center for Pulmonary Vascular Biology and Medicine is devoted to accelerating discoveries about this disease and ensuring these discoveries are applied directly to improve the lives of our patients. We focus our efforts on innovative ways to identify this disease early such that prevention of this disease may be a reality, to identify the elusive molecules that lie at the beginning origins of this disease, and to develop new treatments that could reverse or cure this disease. Inherent to this mission is improving PH awareness and partnership within our community so that we can combat this disease together.

PHenomenal Hope 5K 2018

The Chan Lab represented well at PH Pittsburgh 5K to build awareness and support for our patients with this devastating disease. We also discovered that we have running talent! Looks like we will have to field a Pittsburgh Marathon team as well! Overall Winner of 5K:...

read more

Dr. Chan receives AHA Established Investigator Award

Stephen Chan, MD, PhD, FAHA, has received a 2018 Established Investigator Award from the American Heart Association. The prestigious five-year award honors mid-career investigators with who have shown unusual promise and who have established a record of accomplishment.

read more

Imad al Ghouleh Receives Gilead Research Scholars Award in PAH

We are excited to announce that Imad al Ghouleh, PhD, has received the 2017 Gilead Research Scholars Award in Pulmonary Arterial Hypertension. The mission of this program is to support innovative scientific research that will advance knowledge and understanding in the field of PAH.

read more